Table 3.
All participants (n=43) | Gastro-intestinal*symptoms (n=31) | No gastro-ntestinal symptoms (n=12) | p-value† | ||
---|---|---|---|---|---|
Myeloperoxidase | |||||
Concentration, ng/mL | 1574 (597–3806) | 2225 (812–4033) | 663 (295–2335) | 0·088 | |
Number elevated‡ | 19 (44%) | 16 (52%) | 3 (25%) | 0·11 | |
α1-antitrypsin | |||||
Concentration, μg/mL | 217 (146–438) | 257 (142–475) | 211 (186–261) | 0·80 | |
Number elevated§ | 15 (35%) | 13 (42%) | 2 (17%) | 0·12 | |
Total number of elevated myeloperoxidase or α1-antitrypsin | 23 (53%) | 19 (61%) | 4 (33%) | 0·10 |
Data are n (%) or median (IQR) unless otherwise specified.
Gastrointestinal symptoms of diarrhoea or abdominal pain.
Comparisons between results in those with gastrointestinal symptoms and those without gastrointestinal symptoms were calculated by Mann-Whitney U test for continuous variables and by Fisher's exact test for categorical variables.
Defined as myeloperoxidase >2000 ng/mL.
Defined as α1-antitrypsin >270 μg/mL.